IP Library Granted Patent US 12,557,994
Granted Patent B2
US 12,557,994 · App. 18/136,542 · Granted Feb 24, 2026

Mobile algorithm-based vascular health evaluation processes

Inventor: Alexander F. Castellanos (Templeton, CA)
Assignee: Alexander Castellanos
A61B5/0205A61B5/02007A61B8/0891A61B8/488A61B5/01A61B5/021A61B5/08A61B5/14542A61B8/4427
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,557,994
App. No.
18/136,542
Granted
Feb 24, 2026
Kind
B2
Abstract

Techniques are provided for analyzing data received from at least one portable physiological measuring device that is configured for temporary attachment to a human body. The techniques involve receiving, from sensors temporarily attached to peripheral artery locations of the body, vascular performance data. A portable signal measuring device determines elasticity of one or more blood vessels based on the vascular performance data. This information is input into at least one algorithm that performs an analysis that includes determining one or more changes in the one or more physiological metrics. Based on the analysis, the algorithm determines whether the one or more changes indicate an immediate physiological response or a delayed physiological response, and a severity of the one or more changes.

Claims (55)

1 . A data processing method, comprising:

receiving, from at least one portable physiological measuring device configured for temporary attachment to a human body, data representing one or more physiological metrics of the body;

receiving, from one or more sensors configured for temporary attachment to peripheral artery locations of the body, vascular performance data for the body;

determining, by a portable signal measuring device, elasticity of one or more blood vessels based on the vascular performance data received from the one or more sensors;

inputting the data representing the physiological metrics and the elasticity of the one or more blood vessels to at least one algorithm;

performing, by the at least one algorithm, an analysis based on the physiological metrics and the elasticity of the one or more blood vessels;

wherein performing the analysis comprises:

determining one or more changes in the one or more physiological metrics;

wherein the one or more changes include one or more positive changes or one or more negative changes;

determining whether the one or more changes indicate an immediate physiological response or a delayed physiological response;

determining a number of vascular waveforms represented in the vascular performance data; and

based at least in part on the vascular waveforms, determining an interpretation of severity of the one or more changes;

generating and providing output records comprising one or more recommendations of responsive treatment, reports, animations, or figures based at least in part on the analysis;

wherein the method is performed by one or more computing devices.

2 . The method of claim 1 wherein the data representing one or more physiological metrics includes data indicative of rate of change in heartbeat.

3 . The method of claim 1 wherein the data representing one or more physiological metrics includes data indicative of relative condition of endothelium of the human body.

4 . The method of claim 1 , further comprising:

determining medical condition data indicating one or more medical conditions of the human body based on the at least one algorithm; and

determining recommendations of responsive treatment based on the one or more medical conditions.

5 . The method of claim 4 , wherein determining the medical condition data comprises:

assessing vascular circulation based on stored indication data that correlates particular signals with any one or more of: heart failure, cardiac myopathy, cardiac hypertrophy, enlarged heart, or use of ventricular assisted devices.

6 . The method of claim 1 , wherein performing the analysis further comprises:

determining whether the number of vascular waveforms represents an increase or decrease in the number of vascular waveforms; and

for each of the number of vascular waveforms, determining one or more changes selected from a set of changes that consists of:

a change in blood velocity;

a change in width of waveform; and

a change in blood volume.

7 . The method of claim 1 , wherein the elasticity of the one or more blood vessels is determined based on a bidirectional waveform analysis.

8 . The method of claim 1 , wherein the one or more physiological metrics include at least one of blood pressure, EKG, and spirometry.

9 . The method of claim 1 , wherein the one or more changes include a change representing a blood glucose measure.

10 . The method of claim 1 , wherein the one or more sensors are coupled to the at least one portable physiological measuring device.

11 . The method of claim 1 , wherein the output records comprise any of: a status report on vascular function; a list of options for medical intervention in a patient based on medical standards of practice based on one or more medical indications represented in the vascular performance data; reports or recommendations suggesting sepsis, hypertension, hypotension, or respiratory dysfunction; a protocol for disease intervention; a protocol for nutrition; a protocol for exercise; a protocol for sports performance; a protocol for patient lifestyle or changes in lifestyle; a protocol for patient stress management; a protocol for supplements or medications; a report of recommendations describing nutrition, exercise, supplements, and medications.

12 . A non-transitory computer-readable medium comprising one or more sequences of instructions which when executed using one or more processors cause the one or more processors to perform:

receiving, from at least one portable physiological measuring device configured for temporary attachment to a human body, data representing one or more physiological metrics of the body;

receiving, from one or more sensors configured for temporary attachment to peripheral artery locations of the body, vascular performance data for the body;

determining, by a portable signal measuring device, elasticity of one or more blood vessels based on the vascular performance data received from the one or more sensors;

inputting the data representing the physiological metrics and the elasticity of the one or more blood vessels to at least one algorithm;

performing, by the at least one algorithm, an analysis based on the physiological metrics and the elasticity of the one or more blood vessels;

wherein performing the analysis comprises:

determining one or more changes in the one or more physiological metrics;

wherein the one or more changes include one or more positive changes or one or more negative changes;

determining whether the one or more changes indicate an immediate physiological response or a delayed physiological response;

determining a number of vascular waveforms represented in the vascular performance data; and

based at least in part on the vascular waveforms, determining an interpretation of severity of the one or more changes;

generating and providing output records comprising one or more recommendations of responsive treatment, reports, animations, or figures based at least in part on the analysis.

13 . The computer-readable medium of claim 12 , wherein the one or more sequences of instructions which when executed using the one or more processors cause the one or more processors to perform:

determining medical condition data indicating one or more medical conditions of the body based on the at least one algorithm, wherein determining the medical condition data comprises assessing vascular circulation based on stored indication data that correlates particular signals with any one or more of: heart failure, cardiac myopathy, cardiac hypertrophy, enlarged heart, or use of ventricular assisted devices; and

determining recommendations of responsive treatment based on the one or more medical conditions.

14 . The computer-readable medium of claim 12 , wherein performing the analysis comprises performing assessments of one or more of: vascular circulation, cardiac arrhythmia, extra beats, or premature ventricular contractions.

15 . The computer-readable medium of claim 12 , wherein the physiological measuring device comprises an electrocardiogram EKG apparatus, and wherein performing the analysis comprises correlating EKG data with data.

16 . The computer-readable medium of claim 12 , wherein receiving the data representing the one or more physiological metrics comprises receiving from one or more of any of the following: an infrared, crystal technology, or light-based physiological monitor; a sensor configured for use with augmented reality technology; an auto-fluorescence sensor; a blood pressure sensor; a pulse sensor; a respiratory rate sensor comprising one or more chest patches, wrist patches, and/or chest straps; a body temperature sensor; an oxygen absorption sensor; a carbon dioxide sensor; a nitric oxide sensor; a blood glucose sensor; a sensor of electrolytes, nutrients in circulation, or other metrics; one or more contact lenses configured to measure capillary blood flow; a flow meter; a spirometer; a mouthpiece.

17 . The computer-readable medium of claim 12 , wherein the output records comprise any of: a status report on vascular function; a list of options for medical intervention in a patient based on medical standards of practice based on one or more medical indications represented in the vascular performance data; reports or recommendations suggesting sepsis, hypertension, hypotension, or respiratory dysfunction; a protocol for disease intervention; a protocol for nutrition; a protocol for exercise; a protocol for sports performance; a protocol for patient lifestyle or changes in lifestyle; a protocol for patient stress management; a protocol for supplements or medications; a report of recommendations describing nutrition, exercise, supplements, and medications.

18 . The computer-readable medium of claim 12 , wherein the elasticity of the one or more blood vessels is determined based on a bidirectional waveform Doppler ultrasound analysis.

19 . The computer-readable medium of claim 12 , wherein the one or more changes include a change representing a blood glucose measure.

20 . The computer-readable medium of claim 12 , wherein the one or more sensors are coupled to the at least one portable physiological measuring device.

Continuity (7)
Continuation In Part 17150899 · Jan 15, 2021
Continuation In Part 15225331 · Aug 1, 2016
Continuation 13733079 · Jan 2, 2013
Continuation 13598371 · Aug 29, 2012
Provisional Application 61694728 · Aug 29, 2012
Provisional Application 61528518 · Aug 29, 2011
Related Publication 20230293020A1 · Sep 21, 2023
References Cited (68)
US 4601292A · Fidel et al. · 1986 [cited by applicant]
US 4745924A · Ruff · 1988 [cited by applicant]
US 4802458A · Finsterwald et al. · 1989 [cited by applicant]
US 4860759A · Kahn et al. · 1989 [cited by applicant]
US 5227187A · Wiser et al. · 1993 [cited by applicant]
US 5357427A · Langen et al. · 1994 [cited by applicant]
US 5409009A · Olson · 1995 [cited by applicant]
US 5409010A · Beach et al. · 1995 [cited by applicant]
US 5490516A · Hutson · 1996 [cited by examiner]
US 5529073A · Kielbasiewicz · 1996 [cited by applicant]
US 5662109A · Hutson · 1997 [cited by examiner]
US 5664404A · Ciccotelli et al. · 1997 [cited by applicant]
US 6319201B1 · Wilk · 2001 [cited by applicant]
US 6454712B1 · Oonuki · 2002 [cited by applicant]
US 6612985B2 · Eiffert et al. · 2003 [cited by applicant]
US 6712762B1 · Lichter et al. · 2004 [cited by applicant]
US 7074183B2 · Castellanos · 2006 [cited by applicant]
US 7733224B2 · Tran · 2010 [cited by applicant]
US 10699206B2 · Teixeira · 2020 [cited by applicant]
US 20010032099A1 · Joao · 2001 [cited by applicant]
US 20020035316A1 · Drazen · 2002 [cited by applicant]
US 20020183599A1 · Castellanos · 2002 [cited by examiner]
US 20040102931A1 · Ellis · 2004 [cited by applicant]
US 20040127798A1 · Dala-Krishna · 2004 [cited by examiner]
US 20050228303A1 · Hayano · 2005 [cited by examiner]
US 20060100530A1 · Kliot · 2006 [cited by examiner]
US 20060229506A1 · Castellanos · 2006 [cited by applicant]
US 20070016074A1 · Abreu · 2007 [cited by applicant]
US 20070213600A1 · John · 2007 [cited by examiner]
US 20070225606A1 · Naghavi · 2007 [cited by examiner]
US 20070238995A1 · Sui · 2007 [cited by applicant]
US 20070276270A1 · Tran · 2007 [cited by examiner]
US 20080167572A1 · Stivoric · 2008 [cited by applicant]
US 20080171943A1 · Farringdon · 2008 [cited by applicant]
US 20080221419A1 · Furman · 2008 [cited by examiner]
US 20080255471A1 · Naghavi · 2008 [cited by applicant]
US 20100056873A1 · Allen · 2010 [cited by applicant]
US 20100081941A1 · Naghavi · 2010 [cited by applicant]
US 20100298717A1 · Parfyonov · 2010 [cited by applicant]
US 20110201962A1 · Grudic · 2011 [cited by applicant]
US 20120083715A1 · Yuen · 2012 [cited by applicant]
US 20120290215A1 · Adler · 2012 [cited by applicant]
US 20120310090A1 · Miyachi · 2012 [cited by examiner]
US 20130053655A1 · Castellanos · 2013 [cited by examiner]
US 20190307328A1 · Tran · 2019 [cited by applicant]
Mcginnis, Ra et al., “Biofeedback-assisted relaxation in type 2 diabetes”, Abstract, Diabetes Care dated Sep. 2005:28(9):2145-9. [cited by applicant]
Awad, Elie, “Design of a Wearable Ultrasound Doppler Sensor to Monitor Blood Flow in the Common Carotid Artery”, Massachusetts Institute of Technology, http://hdl.handle.net/1721.1/50070, dated Jun. 1999, 77 pages. [cited by applicant]
Deborah F. Tate PhD, et al., “Using Internet Technology to Deliver a Behavioral Weight Loss Program”, JAMA, Mar. 7, 2001. [cited by applicant]
Hartley, Carolyn P. et al., “A New Look at Disease Management,” The Physician's eHealth Report, vol. 2.6 Nov./Dec. 2005, 12 pages. [cited by applicant]
Haynes, R et al., “Interventions to Enhance Medication Adherence,” Abstract, Cochrane Database Syst Rev Oct. 19, 2005; (4):CD000011. [cited by applicant]
K. Rother, “Framingham Heart Study analysis reveals some primary prevention subgroups are being overlooked”, theheart.org, Oct. 2004), 3 pages. [cited by applicant]
Kaushik, R et al., “Biofeedback assisted diaphragmatic breathing and systematic relaxation versus propranolol in long term prophylaxis of migraine”, Sep. 2005;13(3) pp. 165-174. [cited by applicant]
Keller et al., “Noninavasive Angiography for the Carotid Artery Disease Using Doppler Ultrasound”, dated 1976, pp. 354-363. [cited by applicant]
Krueger, KP et al., “Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiative”, Nov.-Dec. 2003; 43(6):668-78. [cited by applicant]
A. Cohen et al., “A categorization and analysis of the criticisms of Evidence-Based Medicine”, 11 Int'l J. of Medical Informatics 2 (2003), 10 pages. [cited by applicant]
Mcdonald, HP et al., “Interventions to enhance patient adherence to medication prescriptions: scientific review”, Abstract, JAMA Dec. 11, 2002; 288(22), pp. 2868-2879. [cited by applicant]
Tindle, HA et al., “Factors associated with the use of mind body therapies among United States adults with musculoskeletal pain,” Abstract, Complement Ther Med Sep. 2005: 13(3):155-64. [cited by applicant]
Medicine Avenue, Inc., “Products Description”, located on the internet at <http://www.healtheheart.com>, retrieved on Jan. 3, 2004, 2 pages. [cited by applicant]
Nancy Walsh, “Meditation Program Linked to Reduction in Carotid Intima-Media Thickness,” Mar. 1, 2001, Family Practice News, p. 15. [cited by applicant]
Nolan, RP et al., “Heart rate variability biofeedback as a behavioral neurocardiac intervention to enhance vagal heart rate control”, Abstract, 1: Am Heart J Jun. 2005:149(6):1137. [cited by applicant]
Pittler, MH et al., “Complementary therapies for peripheral arterial disease: systematic review”, Abstract, 1 Atherosclerosis Jul. 2005; 181(1):1-7, Mar. 31, 2005. [cited by applicant]
Runck, B., “What is Biofeedback?”, DHHS Pub. No. (ADM) 83-1273, reprinted online by Arizona Behavioral Health Associates, P.C., date unknown, 5 pages. [cited by applicant]
Sanderson et al., “Tissue Doppler imaging for predicting outcome in patients with cardiovascular disease”, Current Opinion in Cardiology, vol. 19, Issue 5, Sep. 2004, 6 pages. [cited by applicant]
Silverman, J., “Partnership Between Physician and Patient is Key to Successful Compliance,” 34 eFamily Practice News 1, Jan. 1, 2004, 1 page. [cited by applicant]
Space Medical, “Products”, 1999, 1 page. [cited by applicant]
Stefano, GB et al., “Integrative medical therapy: examination of meditation's therapeutic and global medicinal outcomes via nitric oxide (review)”, Abstract, Int J Mol Med Oct. 2005;16(4):621-30. [cited by applicant]
M. Zoler, “Framingham Score Drives Coronary Prevention,” 34 eFamily Practice News (Mar. 1, 2004). [cited by applicant]
Matsuo et al., “Intracardiac Flow Dynamics with Bi-directional Ultrasonic Pulsed Doppler Technique:” Symposium On Evaluation of Cardiac Functions Through Non-Invasive Techniques, Japanese Circulation Journal 1977-1978. [cited by applicant]